Australis Scientific Pty Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Australis Scientific Pty Ltd - overview
Established
2021
Location
Sydney, NSW, Australia
Primary Industry
Medical Devices & Equipment
About
Based in Sydney, Australia, and founded in 2021 by its co-founders Nicky Pratama Agahari, and Mihir Shanker and Martin Jensen, Australis Scientific Pty Ltd. operates as a medical devices and equipment company. In November 2025, Australis Scientific Pty Ltd raised AUD 9. 3 million in venture funding led by investor Rohto Pharmaceutical.
The company offers an InConfidence Smart Patch, providing a weekly set-and-forget therapeutic stimulation at home for the treatment of the symptoms of urinary incontinence. This discreet and adaptable patch minimizes chronic symptoms, and its on-demand feature empowers patients to control acute symptoms via a mobile app, eliminating the need for weekly clinic visits. The patent-pending Smart Patch system is based on percutaneous tibial nerve stimulation (PTNS), combining human-centric design with digital medicine. The company will use the November 2025 funding to support its expansion plans and first-in-human clinical trial.
Current Investors
Rohto Pharmaceutical, Butterworth Investments Limited, 10Xventure Ii Llc ()
Primary Industry
Medical Devices & Equipment
Sub Industries
Therapeutic Devices
Website
www.australisscientific.com
Verticals
HealthTech, Mobile Apps, Wearables & Quantified Self
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.